# Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

> **NCT00446329** · PHASE4 · TERMINATED · sponsor: **Papageorgiou General Hospital** · enrollment: 15 (actual)

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** cinacalcet

## Key facts

- **NCT ID:** NCT00446329
- **Lead sponsor:** Papageorgiou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** due to financial problems
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446329, "Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00446329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*